Search - tctmd.com

Displaying 521 - 540 of 764

Sort: Relevancy | Date

Presentation

Paclitaxel-Eluting Balloons, Paclitaxel-Eluting Stents, and Balloon Angioplasty in Patients with Restenosis After DES Implantation

Presenter: Robert A. Byrne

February 07, 2013

News Daily News

ISAR-DESIRE 3 Published: Paclitaxel-Eluting Balloons Match PES for DES Restenosis

Caitlin E. Cox

February 07, 2013

Presentation TCT 2013

Paclitaxel Balloon Delivery Results In Homogeneous In-Stent Neointimal Distribution and Reduction of Stent Edge Stenosis Progression in the Peripheral Swine Model

Presenter: Maxwell Afari, Armando Tellez, Seung-Jin Oh, Piotr Buszman, Yanping Cheng, Jong Shiuan Yeh, Gerard Conditt, Greg Kaluza, Juan Granada

January 31, 2013

Presentation TCT 2013

Vascular Injury Influences Drug Transfer and Vessel Healing Following Paclitaxel Coated Balloon Delivery in the Peripheral Arteries of Swine

Presenter: Maxwell Afari, Taylor Palmieri, Armando Tellez, Piotr Buszman, Krzysztof Milewski, Yanping Cheng, Seung-Jin Oh, Greg Kaluza, Juan Granada

January 31, 2013

Presentation TCT 2013

The Impact of Left Main Disease on Long-term Clinical Outcomes Among Patients Treated With The Unrestricted Use of Everolimus-Eluting, Sirolimus-Eluting, and Paclitaxel-Eluting...

Presenter: Aris Moschovitis, Giulio Stefanini, Michael Magro, Lorenz R?ber, Bindu Kalesan, Masanori Taniwaki, Joost Daemen, Peter Wenaweser, Ron Van Domburg, Bernhard Meier, Peter Juni, Patrick Serruys, Stephan Windecker

January 31, 2013

Presentation TCT 2013

PAclitaxel-eluting Balloon In Primary Percutaneous Coronary Intervention In Amsterdam (PAPPA): Sustained Safety And Efficacy At 12 Months Follow-up.

Presenter: Nicola Vos, Maurits Dirksen, Ferdinand Van Nooijen, Ton Slagboom, Giovanni Amoroso, Ferdinand Kiemeneij, Mark Patterson, Jean-Paul Herrman, Ren? Van der Schaaf

January 31, 2013

Presentation TCT 2013

Paclitaxel Drug Eluting Balloon Versus Standard Angioplasty To Reduce Restenosis In Diabetic Patients With In Stent Restenosis Of The Superficial Femoral And Proximal Popliteal...

Presenter: Francesco Liistro, Paolo Angioli, Guido Bellandi, Leonardo Bolognese, Kenneth Ducci, Italo Porto, Filippo Turini, Giorgio Ventoruzzo

January 31, 2013

Presentation TCT 2013

Neointimal Tissue Characteristics Based on Optical Coherence Tomography Analysis Following Paclitaxel Coated Balloon Treatment in a Porcine Iliofemoral Vascular Territory

Presenter: Maxwell Afari, Seung-Jin Oh, Piotr Buszman, Armando Tellez, Athanasios Peppas, William Rate, Jong Shiuan Yeh, Greg Kaluza, Juan Granada

January 31, 2013

Presentation TCT 2013

Impact of Varying Injury Severity and Multiple Treatments on Arterial Histopathology Early After Paclitaxel Coated Balloon Treatment of the Iliofemoral Arteries of Domestic Swine

Presenter: Maxwell Afari, Armando Tellez, Seung-Jin Oh, Krzysztof Milewski, Piotr Buszman, Renu Virmani, Juan Granada, Greg Kaluza

January 31, 2013

Presentation TCT 2013

Impact of Baseline Peri-Stent Plaque Volume on Positive Vessel Remodeling after Implantation of Paclitaxel Eluting Stents: A Pooled Volumetric Intravascular Ultrasound Analysis

Presenter: Kenji Sakamoto, Katsuhisa Waseda, Hideki Kitahara, Ryotaro Yamada, Ching-Chang Huang, Paul Yock, Peter Fitzgerald, Yasuhiro Honda

January 31, 2013

Presentation TCT 2013

Everolimus Eluting Stents Versus First Generation Drug Eluting Stents (Sirolimus or Paclitaxel) for Treatment of Drug-Eluting Stent In-Stent Restenosis

Presenter: Sachin Goel, Wael El-Mallah, Mobolaji Ige, Supriya Gupta, E Murat Tuzcu, Stephen Ellis, Samir Kapadia

January 31, 2013

Presentation TCT 2013

Evaluation of Long-term Vascular Responses to Fluorocopolymer coated Self-Expanding low-dose Paclitaxel-eluting Stent in Porcine Ilio-femoral Model

Presenter: Dongming Hou, Barbara Huibregtse, William Stoffregen, Gordon Kocur, Cory Hitzman, Elizabeth Stejskal, John Heil, Keith Dawkins

January 31, 2013

Presentation TCT 2013

Cost-effectiveness of paclitaxel-coated balloon angioplasty for treatment of coronary restenosis in bare-metal stents

Presenter: Klaus Bonaventura, Alexander Leber, Christian Sohns, Mattias Roser, Leif-Hendrik Boldt, Wilhelm Haverkamp, Marc Dorenkamp

January 31, 2013

Presentation TCT 2013

Biological Efficacy and Vessel Healing of Second Generation Paclitaxel Coated Balloons: A Comparative Study with the original PACCOCATH Technology in the Ilio-Femoral In-Stent...

Presenter: Piotr Buszman, Armando Tellez, Maxwell Afari, Jenn McGregor, Yanping Cheng, Gerard Conditt, Serge Rousselle, Greg Kaluza, Juan Granada

January 31, 2013

Presentation TCT 2013

Biodegradable-Polymer Biolimus Eluting Stents Show Better Antiproliferative Efficacy And Vascular Healing Pattern Than Permanent-Polymer Paclitaxel Eluting Stents in a Preclinic...

Presenter: Armando P?rez de Prado, Claudia P?rez-Mart?nez, Alejandro Diego, Jos? Manuel Gonzalo-Orden, Carlos Cuellas, Marta Regueiro, Beatriz Mart?nez-Fern?ndez, Jose M Ajenjo, Maria J Garcia-Iglesias, Felipe Fern?ndez-V?zquez

January 31, 2013

Presentation TCT 2013

Bare-nitinol stent versus paclitaxel-coated balloon for femoro-popliteal revascularization. An adjusted indirect comparison meta-analysis of randomized trials

Presenter: Salvatore Cassese, Robert Byrne, Ilka Ott, Tareq Ibrahim, Tomohisa Tada, Lamin King, Adnan Kastrati, Massimiliano Fusaro

January 31, 2013

News Daily News

Self-Expanding Nitinol Stent Potential Option in Popliteal Artery Disease

January 24, 2013

News Daily News

La Duración Ideal de la Terapia Antiplaquetaria Doble podría Depender del Tipo de Stent

Jason Kahn

January 22, 2013

News Daily News

Ideal Duration of Dual Antiplatelet Therapy May Depend on Stent Type

Jason Kahn

January 22, 2013

News Daily News

TCTMD’s Top 10 Most Popular News Stories for 2012

Jason Kahn

January 02, 2013

Advertisement

Paclitaxel-Eluting Balloons, Paclitaxel-Eluting Stents, and Balloon Angioplasty in Patients with Restenosis After DES Implantation

ISAR-DESIRE 3 Published: Paclitaxel-Eluting Balloons Match PES for DES Restenosis

Paclitaxel Balloon Delivery Results In Homogeneous In-Stent Neointimal Distribution and Reduction of Stent Edge Stenosis Progression in the Peripheral Swine Model

Vascular Injury Influences Drug Transfer and Vessel Healing Following Paclitaxel Coated Balloon Delivery in the Peripheral Arteries of Swine

The Impact of Left Main Disease on Long-term Clinical Outcomes Among Patients Treated With The Unrestricted Use of Everolimus-Eluting, Sirolimus-Eluting, and Paclitaxel-Eluting...

PAclitaxel-eluting Balloon In Primary Percutaneous Coronary Intervention In Amsterdam (PAPPA): Sustained Safety And Efficacy At 12 Months Follow-up.

Paclitaxel Drug Eluting Balloon Versus Standard Angioplasty To Reduce Restenosis In Diabetic Patients With In Stent Restenosis Of The Superficial Femoral And Proximal Popliteal...

Neointimal Tissue Characteristics Based on Optical Coherence Tomography Analysis Following Paclitaxel Coated Balloon Treatment in a Porcine Iliofemoral Vascular Territory

Impact of Varying Injury Severity and Multiple Treatments on Arterial Histopathology Early After Paclitaxel Coated Balloon Treatment of the Iliofemoral Arteries of Domestic Swine

Impact of Baseline Peri-Stent Plaque Volume on Positive Vessel Remodeling after Implantation of Paclitaxel Eluting Stents: A Pooled Volumetric Intravascular Ultrasound Analysis

Everolimus Eluting Stents Versus First Generation Drug Eluting Stents (Sirolimus or Paclitaxel) for Treatment of Drug-Eluting Stent In-Stent Restenosis

Evaluation of Long-term Vascular Responses to Fluorocopolymer coated Self-Expanding low-dose Paclitaxel-eluting Stent in Porcine Ilio-femoral Model

Cost-effectiveness of paclitaxel-coated balloon angioplasty for treatment of coronary restenosis in bare-metal stents

Biological Efficacy and Vessel Healing of Second Generation Paclitaxel Coated Balloons: A Comparative Study with the original PACCOCATH Technology in the Ilio-Femoral In-Stent...

Biodegradable-Polymer Biolimus Eluting Stents Show Better Antiproliferative Efficacy And Vascular Healing Pattern Than Permanent-Polymer Paclitaxel Eluting Stents in a Preclinic...

Bare-nitinol stent versus paclitaxel-coated balloon for femoro-popliteal revascularization. An adjusted indirect comparison meta-analysis of randomized trials

Self-Expanding Nitinol Stent Potential Option in Popliteal Artery Disease

La Duración Ideal de la Terapia Antiplaquetaria Doble podría Depender del Tipo de Stent

Ideal Duration of Dual Antiplatelet Therapy May Depend on Stent Type

TCTMD’s Top 10 Most Popular News Stories for 2012

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content